RxSight, Inc. (RXST)
7.03
+0.04
(+0.57%)
USD |
NASDAQ |
Sep 02, 16:00
7.03
0.00 (0.00%)
After-Hours: 17:53
RxSight Research and Development Expense (TTM) : 36.67M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.67M |
| March 31, 2026 | 37.65M |
| December 31, 2025 | 38.55M |
| September 30, 2025 | 38.85M |
| June 30, 2025 | 38.63M |
| March 31, 2025 | 36.70M |
| December 31, 2024 | 34.37M |
| September 30, 2024 | 32.50M |
| June 30, 2024 | 30.76M |
| March 31, 2024 | 29.87M |
| December 31, 2023 | 29.05M |
| Date | Value |
|---|---|
| September 30, 2023 | 28.39M |
| June 30, 2023 | 27.68M |
| March 31, 2023 | 26.47M |
| December 31, 2022 | 25.98M |
| September 30, 2022 | 25.22M |
| June 30, 2022 | 24.20M |
| March 31, 2022 | 24.58M |
| December 31, 2021 | 24.50M |
| September 30, 2021 | 23.67M |
| June 30, 2021 | 24.07M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Precision Optics Corp., Inc. | 1.057M |
| Alcon AG | 1.431B |
| The Cooper Cos., Inc. | 172.80M |
| UFP Technologies, Inc. | -- |
| TransMedics Group, Inc. | 92.47M |